Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Tucker, E.R. Jiménez, I. Chen, L. Bellini, A. Gorrini, C. Calton, E. Gao, Q. Che, H. Poon, E. Jamin, Y. Martins Da Costa, B. Barker, K. Shrestha, S. Hutchinson, J.C. Dhariwal, S. Goodman, A. Del Nery, E. Gestraud, P. Bhalshankar, J. Iddir, Y. Saberi-Ansari, E. Saint-Charles, A. Geoerger, B. Marques Da Costa, M.E. Pierre-Eugène, C. Janoueix-Lerosey, I. Decaudin, D. Nemati, F. Carcaboso, A.M. Surdez, D. Delattre, O. George, S.L. Chesler, L. Tweddle, D.A. Schleiermacher, G. (2023). Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models. Clin cancer res, Vol.29 (7), pp. 1317-1331.  show abstract  full text

Stankunaite, R. George, S.L. Gallagher, L. Jamal, S. Shaikh, R. Yuan, L. Hughes, D. Proszek, P.Z. Carter, P. Pietka, G. Heide, T. James, C. Tari, H. Lynn, C. Jain, N. Portela, L.R. Rogers, T. Vaidya, S.J. Chisholm, J.C. Carceller, F. Szychot, E. Mandeville, H. Angelini, P. Jesudason, A.B. Jackson, M. Marshall, L.V. Gatz, S.A. Anderson, J. Sottoriva, A. Chesler, L. Hubank, M. (2022). Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours. Eur j cancer, Vol.162, pp. 209-220.  show abstract  full text

Ruhen, O. Lak, N.S. Stutterheim, J. Danielli, S.G. Chicard, M. Iddir, Y. Saint-Charles, A. Di Paolo, V. Tombolan, L. Gatz, S.A. Aladowicz, E. Proszek, P. Jamal, S. Stankunaite, R. Hughes, D. Carter, P. Izquierdo, E. Wasti, A. Chisholm, J.C. George, S.L. Pace, E. Chesler, L. Aerts, I. Pierron, G. Zaidi, S. Delattre, O. Surdez, D. Kelsey, A. Hubank, M. Bonvini, P. Bisogno, G. Di Giannatale, A. Schleiermacher, G. Schäfer, B.W. Tytgat, G.A. Shipley, J. (2022). Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study. Jco precis oncol, Vol.6, p. e2100534.  show abstract  full text

Stankunaite, R. Marshall, L.V. Carceller, F. Chesler, L. Hubank, M. George, S.L. (2022). Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations. Front pediatr, Vol.10, p. 957944.  show abstract  full text

Shern, J.F. Selfe, J. Izquierdo, E. Patidar, R. Chou, H.-. Song, Y.K. Yohe, M.E. Sindiri, S. Wei, J. Wen, X. Rudzinski, E.R. Barkauskas, D.A. Lo, T. Hall, D. Linardic, C.M. Hughes, D. Jamal, S. Jenney, M. Chisholm, J. Brown, R. Jones, K. Hicks, B. Angelini, P. George, S. Chesler, L. Hubank, M. Kelsey, A. Gatz, S.A. Skapek, S.X. Hawkins, D.S. Shipley, J.M. Khan, J. (2021). Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium. J clin oncol, Vol.39 (26), pp. 2859-2871.  show abstract  full text

Bellini, A. Pötschger, U. Bernard, V. Lapouble, E. Baulande, S. Ambros, P.F. Auger, N. Beiske, K. Bernkopf, M. Betts, D.R. Bhalshankar, J. Bown, N. de Preter, K. Clément, N. Combaret, V. Font de Mora, J. George, S.L. Jiménez, I. Jeison, M. Marques, B. Martinsson, T. Mazzocco, K. Morini, M. Mühlethaler-Mottet, A. Noguera, R. Pierron, G. Rossing, M. Taschner-Mandl, S. Van Roy, N. Vicha, A. Chesler, L. Balwierz, W. Castel, V. Elliott, M. Kogner, P. Laureys, G. Luksch, R. Malis, J. Popovic-Beck, M. Ash, S. Delattre, O. Valteau-Couanet, D. Tweddle, D.A. Ladenstein, R. Schleiermacher, G. (2021). Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). J clin oncol, Vol.39 (30), pp. 3377-3390.  show abstract  full text

Tucker, E.R. George, S. Angelini, P. Bruna, A. Chesler, L. (2021). The Promise of Patient-Derived Preclinical Models to Accelerate the Implementation of Personalised Medicine for Children with Neuroblastoma. J pers med, Vol.11 (4).  show abstract  full text

George, S.L. Parmar, V. Lorenzi, F. Marshall, L.V. Jamin, Y. Poon, E. Angelini, P. Chesler, L. (2020). Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. J exp clin cancer res, Vol.39 (1), p. 78.  show abstract  full text

George, S.L. Lorenzi, F. King, D. Hartlieb, S. Campbell, J. Pemberton, H. Toprak, U.H. Barker, K. Tall, J. da Costa, B.M. van den Boogaard, M.L. Dolman, M.E. Molenaar, J.J. Bryant, H.E. Westermann, F. Lord, C.J. Chesler, L. (2020). Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma. Ebiomedicine, Vol.59, p. 102971.  show abstract  full text

Moreno, L. Barone, G. DuBois, S.G. Molenaar, J. Fischer, M. Schulte, J. Eggert, A. Schleiermacher, G. Speleman, F. Chesler, L. Geoerger, B. Hogarty, M.D. Irwin, M.S. Bird, N. Blanchard, G.B. Buckland, S. Caron, H. Davis, S. De Wilde, B. Deubzer, H.E. Dolman, E. Eilers, M. George, R.E. George, S. Jaroslav, Š. Maris, J.M. Marshall, L. Merchant, M. Mortimer, P. Owens, C. Philpott, A. Poon, E. Shay, J.W. Tonelli, R. Valteau-Couanet, D. Vassal, G. Park, J.R. Pearson, A.D. (2020). Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. Eur j cancer, Vol.136, pp. 52-68.  show abstract  full text

George, S.L. Izquierdo, E. Campbell, J. Koutroumanidou, E. Proszek, P. Jamal, S. Hughes, D. Yuan, L. Marshall, L.V. Carceller, F. Chisholm, J.C. Vaidya, S. Mandeville, H. Angelini, P. Wasti, A. Bexelius, T. Thway, K. Gatz, S.A. Clarke, M. Al-Lazikani, B. Barone, G. Anderson, J. Tweddle, D.A. Gonzalez, D. Walker, B.A. Barton, J. Depani, S. Eze, J. Ahmed, S.W. Moreno, L. Pearson, A. Shipley, J. Jones, C. Hargrave, D. Jacques, T.S. Hubank, M. Chesler, L. (2019). A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur j cancer, Vol.121, pp. 224-235.  show abstract  full text

Yogev, O. Almeida, G.S. Barker, K.T. George, S.L. Kwok, C. Campbell, J. Zarowiecki, M. Kleftogiannis, D. Smith, L.M. Hallsworth, A. Berry, P. Möcklinghoff, T. Webber, H.T. Danielson, L.S. Buttery, B. Calton, E.A. da Costa, B.M. Poon, E. Jamin, Y. Lise, S. Veal, G.J. Sebire, N. Robinson, S.P. Anderson, J. Chesler, L. (2019). In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis. Cancer res, Vol.79 (20), pp. 5382-5393.  show abstract  full text

Moreno, L. Caron, H. Geoerger, B. Eggert, A. Schleiermacher, G. Brock, P. Valteau-Couanet, D. Chesler, L. Schulte, J.H. De Preter, K. Molenaar, J. Schramm, A. Eilers, M. Van Maerken, T. Johnsen, J.I. Garrett, M. George, S.L. Tweddle, D.A. Kogner, P. Berthold, F. Koster, J. Barone, G. Tucker, E.R. Marshall, L. Herold, R. Sterba, J. Norga, K. Vassal, G. Pearson, A.D. (2017). Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. Expert opin drug discov, Vol.12 (8), pp. 801-811.  show abstract  full text

Izquierdo, E. Yuan, L. George, S. Hubank, M. Jones, C. Proszek, P. Shipley, J. Gatz, S.A. Stinson, C. Moore, A.S. Clifford, S.C. Hicks, D. Lindsey, J.C. Hill, R.M. Jacques, T.S. Chalker, J. Thway, K. O'Connor, S. Marshall, L. Moreno, L. Pearson, A. Chesler, L. Walker, B.A. De Castro, D.G. (2017). Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours. Oncotarget, Vol.8 (67), pp. 112036-112050.  show abstract  full text

George, S.L. Falzone, N. Chittenden, S. Kirk, S.J. Lancaster, D. Vaidya, S.J. Mandeville, H. Saran, F. Pearson, A.D. Du, Y. Meller, S.T. Denis-Bacelar, A.M. Flux, G.D. (2016). Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma. Nucl med commun, Vol.37 (5), pp. 466-472.  show abstract  full text

George, S.L. Falzone, N. Chittenden, S. Kirk, S.J. Lancaster, D. Vaidya, S.J. Mandeville, H. Saran, F. Pearson, A.D. Du, Y. Meller, S.T. Denis-Bacelar, A.M. Flux, G.D. (2016). Individualized I-131-mIBG therapy in the management of refractory and relapsed neuroblastoma. Nuclear medicine communications, Vol.37 (5), pp. 466-472.  full text

In this section

Publications